A Study of Ixekizumab in Participants With Plaque Psoriasis

I1F-MC-RHBU -

The purpose of this study is to learn about how ixekizumab may affect the blood levels of a mixture of commonly used drugs.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Plaque Psoriasis
What the trial is testing?
Ixekizumab
Could I receive a Placebo?
No
Enrollment Goal
28
Trial Dates
Dec 22, 2016 - Nov 21, 2017
How long will I be in the trial?
Your participation could last up to 5 months with 6 overnight stays and approximately 13 outpatient visits.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.